✦ LIBER ✦

Patient Selection for Treatment Modality in Stage III Non-small Cell Lung Cancer: A Population-based Analysis

✍ Scribed by Gomez, D.R.; Liao, K.; Chang, J.Y.; Liao, Z.; Shirvani, S.M.; Komaki, R.; Welsh, J.W.; Swisher, S.G.; Heymach, J.V.; Smith, B.D.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Combined modality treatment for Stage II

✍ Bonomi, Philip 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 708 KB

Combined modality treatment for stage II

📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 136 KB

Treatment Modality and Other Prognostic

✍ Gomez, D.R.; Liao, K.; Chang, J.Y.; Liao, Z.; Shirvani, S.M.; Komaki, R.; Welsh, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 53 KB

Pre-treatment prognostic factors in stag

✍ Philip Bonomi; Meryl Gale; Kendrith Rowland; Samuel G. Taylor IV; Sandra Purl; S 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 745 KB

O-95 Combined modality therapy in a popu

✍ Wai, Elaine S.; Moravan, Veronika; Truong, Pauline; Berthelet, Eric; Lim, Jan T. 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

Time to Treatment in Patients With Stage

✍ Li Wang; Candace R. Correa; James A. Hayman; Lujun Zhao; Kemp Cease; Dean Brenne 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 216 KB